A citation-based method for searching scientific literature

Tarinee Manchana, Prasit Phowthongkum, Chinachote Teerapakpinyo. World J Clin Oncol 2019
Times Cited: 3







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


BRCA mutation in high grade epithelial ovarian cancers.
Tarinee Manchana, Natacha Phoolcharoen, Patou Tantbirojn. Gynecol Oncol Rep 2019
15
66


Current role of poly(ADP-ribose) polymerase inhibitors: which poly(ADP-ribose) polymerase inhibitor and when?
Hélène Vanacker, Clémence Romeo, Isabelle Ray-Coquard. Curr Opin Oncol 2019
2
50

The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancer.
J L Meisel, D M Hyman, K Garg, Q Zhou, F Dao, M Bisogna, J Gao, N D Schultz, R N Grisham, M Phillips,[...]. Ann Oncol 2014
24
33

BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing.
Andrea Mafficini, Michele Simbolo, Alice Parisi, Borislav Rusev, Claudio Luchini, Ivana Cataldo, Elena Piazzola, Nicola Sperandio, Giona Turri, Massimo Franchi,[...]. Oncotarget 2016
49
33

Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
338
33


BRCA1 expression in a large series of sporadic ovarian carcinomas: a Gynecologic Oncology Group study.
M Thrall, H H Gallion, R Kryscio, M Kapali, D K Armstrong, Julie A DeLoia. Int J Gynecol Cancer 2006
60
33

The Prognostic Value of BRCA1 and PARP Expression in Epithelial Ovarian Carcinoma: Immunohistochemical Detection.
Mette Hjortkjær, Marianne Waldstrøm, Anders Jakobsen, Hanne Kanstrup, Erik Søgaard-Andersen, Karina Dahl Steffensen. Int J Gynecol Pathol 2017
18
33

BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer.
M Moschetta, A George, S B Kaye, S Banerjee. Ann Oncol 2016
86
33

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.
Kelly L Bolton, Georgia Chenevix-Trench, Cindy Goh, Siegal Sadetzki, Susan J Ramus, Beth Y Karlan, Diether Lambrechts, Evelyn Despierre, Daniel Barrowdale, Lesley McGuffog,[...]. JAMA 2012
363
33

BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomas.
Karuna Garg, Douglas A Levine, Narciso Olvera, Fanny Dao, Maria Bisogna, Angeles Alvarez Secord, Andrew Berchuck, Ethan Cerami, Nikolaus Schultz, Robert A Soslow. Am J Surg Pathol 2013
37
33

Familial breast/ovarian cancer and BRCA1/2 genetic screening: the role of immunohistochemistry as an additional method in the selection of patients.
Fátima H Vaz, Patrícia M Machado, Rita D Brandão, Cátia T Laranjeira, Joana S Eugénio, Aires H Fernandes, Saudade P André. J Histochem Cytochem 2007
16
33

BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer.
Judith E Carser, Jennifer E Quinn, Caroline O Michie, Eamonn J O'Brien, W Glenn McCluggage, Perry Maxwell, Elisabeth Lamers, Tong F Lioe, Alistair R W Williams, Richard D Kennedy,[...]. Gynecol Oncol 2011
52
33

Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review.
Marieke Arts-de Jong, Geertruida H de Bock, Christi J van Asperen, Marian J E Mourits, Joanne A de Hullu, C Marleen Kets. Eur J Cancer 2016
37
33

Identification of BRCA1-deficient ovarian cancers.
Anne-Bine Skytte, Marianne Waldstrøm, Anders Aamann Rasmussen, Dorthe Crüger, Emma R Woodward, Steen Kølvraa. Acta Obstet Gynecol Scand 2011
13
33

Homologous recombination deficiency and ovarian cancer.
Jonathan A Ledermann, Yvette Drew, Rebecca S Kristeleit. Eur J Cancer 2016
89
33

BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study.
J L Lesnock, K M Darcy, C Tian, J A Deloia, M M Thrall, C Zahn, D K Armstrong, M J Birrer, T C Krivak. Br J Cancer 2013
87
33

Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an NCIC CTG OV.16 correlative study.
J I Weberpals, D Tu, J A Squire, M S Amin, S Islam, L B Pelletier, A M O'Brien, P J Hoskins, E A Eisenhauer. Ann Oncol 2011
32
33

BRCA2 alteration is important in clear cell carcinoma of the ovary.
M J Goodheart, S L Rose, M Hattermann-Zogg, B J Smith, B R De Young, R E Buller. Clin Genet 2009
11
33

Ovarian cancer statistics, 2018.
Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2018
910
33

Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management.
Renata Rodrigues da Cunha Colombo Bonadio, Rodrigo Nogueira Fogace, Vanessa Costa Miranda, Maria Del Pilar Estevez Diz. Clinics (Sao Paulo) 2018
28
33

Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer.
Angel Chao, Ting-Chang Chang, Nina Lapke, Shih-Ming Jung, Peter Chi, Chien-Hung Chen, Lan-Yan Yang, Cheng-Tao Lin, Huei-Jean Huang, Hung-Hsueh Chou,[...]. Oncotarget 2016
28
33

Chemotherapy for epithelial ovarian, fallopian tube and primary peritoneal cancer.
Kate Webber, Michael Friedlander. Best Pract Res Clin Obstet Gynaecol 2017
20
33

Assessment of the quality of DNA from various formalin-fixed paraffin-embedded (FFPE) tissues and the use of this DNA for next-generation sequencing (NGS) with no artifactual mutation.
Naoki Einaga, Akio Yoshida, Hiroko Noda, Masaaki Suemitsu, Yuki Nakayama, Akihisa Sakurada, Yoshiko Kawaji, Hiromi Yamaguchi, Yasushi Sasaki, Takashi Tokino,[...]. PLoS One 2017
46
33

The epidemiologic status of gynecologic cancer in Thailand.
Sarikapan Wilailak, Nuttapong Lertchaipattanakul. J Gynecol Oncol 2016
13
33

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Panagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N Grisham, Paul J Goodfellow, Elise C Kohn, Douglas A Levine, Joyce F Liu, Karen H Lu,[...]. J Clin Oncol 2020
48
33

Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients.
Ignace Vergote, Susana Banerjee, Anne-Marie Gerdes, Christi van Asperen, Christian Marth, Fatima Vaz, Isabelle Ray-Coquard, Dominique Stoppa-Lyonnet, Antonio Gonzalez-Martin, Jalid Sehouli,[...]. Eur J Cancer 2016
33
33

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.
Jonathan Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare L Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra,[...]. Lancet Oncol 2014
845
33

The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients.
Xiaohua Wu, Lingying Wu, Beihua Kong, Jihong Liu, Rutie Yin, Hao Wen, Ning Li, Hualei Bu, Yanling Feng, Qingli Li,[...]. Int J Gynecol Cancer 2017
30
33

The first Japanese nationwide multicenter study of BRCA mutation testing in ovarian cancer: CHARacterizing the cross-sectionaL approach to Ovarian cancer geneTic TEsting of BRCA (CHARLOTTE).
Takayuki Enomoto, Daisuke Aoki, Kana Hattori, Masahisa Jinushi, Junzo Kigawa, Nobuhiro Takeshima, Hitoshi Tsuda, Yoh Watanabe, Kosuke Yoshihara, Toru Sugiyama. Int J Gynecol Cancer 2019
32
33

Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives.
Stefania Gori, Massimo Barberis, Maria Angela Bella, Fiamma Buttitta, Ettore Capoluongo, Paola Carrera, Nicoletta Colombo, Laura Cortesi, Maurizio Genuardi, Massimo Gion,[...]. Crit Rev Oncol Hematol 2019
28
33

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
33


Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.
Eric Pujade-Lauraine, Jonathan A Ledermann, Frédéric Selle, Val Gebski, Richard T Penson, Amit M Oza, Jacob Korach, Tomasz Huzarski, Andrés Poveda, Sandro Pignata,[...]. Lancet Oncol 2017
691
33


The clinical features associated with mutated BRCA1 and 2 genes in ovarian cancer patients.
Paul Kubelac, Catalin Vlad, Ioana Berindan Neagoe, Alexandru Irimie, Patriciu Achimas Cadariu. J BUON 2019
3
33

Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer.
Bryan T J Hennessy, Kirsten M Timms, Mark S Carey, Alexander Gutin, Larissa A Meyer, Darl D Flake, Victor Abkevich, Jennifer Potter, Dmitry Pruss, Pat Glenn,[...]. J Clin Oncol 2010
241
33

Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting.
Brian A Dougherty, Zhongwu Lai, Darren R Hodgson, Maria C M Orr, Matthew Hawryluk, James Sun, Roman Yelensky, Stuart K Spencer, Jane D Robertson, Tony W Ho,[...]. Oncotarget 2017
48
33

Clinical and Genetic Characteristics of BRCA1/2 Mutation in Korean Ovarian Cancer Patients: A Multicenter Study and Literature Review.
Byung Su Kwon, Jung Mi Byun, Hyun Joo Lee, Dae Hoon Jeong, Tae Hwa Lee, Kyung-Hwa Shin, Dong Soo Suh, Ki Hyung Kim. Cancer Res Treat 2019
6
33

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.
Marilyn M Li, Michael Datto, Eric J Duncavage, Shashikant Kulkarni, Neal I Lindeman, Somak Roy, Apostolia M Tsimberidou, Cindy L Vnencak-Jones, Daynna J Wolff, Anas Younes,[...]. J Mol Diagn 2017
535
33

Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene.
H More, B Humar, W Weber, R Ward, A Christian, C Lintott, F Graziano, A-M Ruzzo, E Acosta, B Boman,[...]. Hum Mutat 2007
62
33

A new perspective on blame culture: an experimental study.
Alessandra Gorini, Massimo Miglioretti, Gabriella Pravettoni. J Eval Clin Pract 2012
17
33

E-cadherin germline mutations in familial gastric cancer.
P Guilford, J Hopkins, J Harraway, M McLeod, N McLeod, P Harawira, H Taite, R Scoular, A Miller, A E Reeve. Nature 1998
33

Predicting the Functional Impact of CDH1 Missense Mutations in Hereditary Diffuse Gastric Cancer.
Soraia Melo, Joana Figueiredo, Maria Sofia Fernandes, Margarida Gonçalves, Eurico Morais-de-Sá, João Miguel Sanches, Raquel Seruca. Int J Mol Sci 2017
26
33

Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening.
Fátima Carneiro, David G Huntsman, Thomas C Smyrk, David A Owen, Raquel Seruca, Paul Pharoah, Carlos Caldas, Manuel Sobrinho-Simões. J Pathol 2004
174
33

Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy.
Henry T Lynch, Pardeep Kaurah, Debrah Wirtzfeld, Wendy S Rubinstein, Scott Weissman, Jane F Lynch, William Grady, Sara Wiyrick, Janine Senz, David G Huntsman. Cancer 2008
56
33

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
33

CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study.
Patrick R Benusiglio, David Malka, Etienne Rouleau, Antoine De Pauw, Bruno Buecher, Catherine Noguès, Emmanuelle Fourme, Chrystelle Colas, Florence Coulet, Mathilde Warcoin,[...]. J Med Genet 2013
85
33

Gastric cancer: epidemiology, biology, and prevention: a mini review.
Kiara Lyons, Linh C Le, Yen T-H Pham, Claire Borron, Jong Y Park, Chi T D Tran, Thuan V Tran, Huong T-T Tran, Khanh T Vu, Cuong D Do,[...]. Eur J Cancer Prev 2019
28
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.